View all research projects
Research project

Production of Technology Assessment Reviews (TARs) for the National Institute of Health Research (NIHR) 2016-2022

Staff

Lead researchers

Professor Andrew Cook MBBS MPH FFPH

Prof of Health Technology Assessment
Research interests
  • Pragmatic Clinical Trials
  • Research Conduct
  • Guidelines
Connect with Andrew

Email: andrewc@soton.ac.uk

Other researchers

Professor Joanne Lord

Director of SHTAC
Research interests
  • Joanne has research interests in health economic evaluation and decision modelling.
  • She has worked on a wide range of applied cost-effectiveness studies, including:
  • a review of newborn screening for inborn errors of metabolism;trials of diagnosis, patient ed…
Connect with Joanne

Email: J.Lord@soton.ac.uk

Collaborating research institutes, centres and groups

Research outputs

Apalutamide for treating prostate cancer - A Single Technology Appraisal
Keith Cooper, Irina Tikhonova, Lois Woods, Lorna Hazell, Ines Ribeiro, Joanna Picot, David Alexander Scott & Jonathan Shepherd, 2020
Type: report
Daratumumab in combination for untreated multiple myeloma when stem cell transplant is suitable [ID1510]
Joanne Lord, Neelam Kalita, Lois Woods, Lorna Hazell, David Alexander Scott & Geoff Frampton, 2020
Type: report
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea
Irina Tikhonova, Lorna Hazell, Joanne Lord, Joanna Picot, Oluchukwu O Onyimadu & Jonathan Shepherd, 2020
Type: report
Dupilumab for treating severe asthma: Report for NICE Technology Appraisal (TA751)
Joanne Lord, Neelam Kalita, Keith Cooper, Geoff Frampton, David Alexander Scott & Joanna Picot, 2019
Type: report
Budesonide for treating eosinophilic oesophagitis:
Joanna Picot, Keith Cooper, Neelam Kalita, David Alexander Scott & Jonathan Shepherd, 2019
Type: report
Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinoma: a Single Technology Appraisal
Neelam Kalita, Joanne Lord, J. Colquitt, E. Loveman, David A. Scott & Geoffrey Frampton, 2019
Type: report
Ustekinumab for treating moderately to severely active ulcerative colitis
Neelam Kalita, Joanne Lord, Karen Pickett, David A. Scott & Geoffrey Frampton, 2019
Type: report